Maud Santillana-Hayat
Centre national de la recherche scientifique
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Maud Santillana-Hayat.
Antimicrobial Agents and Chemotherapy | 2002
Maud Santillana-Hayat; Claudine Sarfati; Sandra Fournier; Françoise Chau; Raphael Porcher; Jean-Michel Molina; Francis Derouin
ABSTRACT We combined tissue culture and flow cytometry to assess the activities of various temperatures, chemicals, and disinfectants on the viability and infectivity of spores of Encephalitozoon intestinalis. Surfanios and benzalkonium chloride, disinfectants currently used in the hospital, were remarkably efficient in destroying spore viability and infectivity.
Antimicrobial Agents and Chemotherapy | 2000
Francis Derouin; Maud Santillana-Hayat
ABSTRACT The anti-Toxoplasma activities of nine antiretroviral drugs were examined in vitro. Nucleoside analogs had no effect on parasite growth, whereas ritonavir and nelfinavir were inhibitory for Toxoplasma, with 50% inhibitory concentrations of 5.4 and 4.0 μg/ml, respectively. None of the antiviral drugs affected the anti-Toxoplasmaactivity of pyrimethamine or sulfadiazine.
Research in Virology | 1993
Maud Santillana-Hayat; F. Rozain; P. Bittoun; C. Chopin-Robert; J. Lasneret; J. Peries; Martine Canivet
Spumaviruses (foamy viruses) constitute one of the three retroviral genera isolated from man. Although spumaviruses have not been clearly linked to a given pathology in humans and other infected species, it is well established that they lead in vivo to chronic infections without detectable viral expression. We thought it of interest to investigate certain aspects of the pathology induced in laboratory animals by human foamy virus (HFV). In this work, we demonstrate that HFV infection of rabbits and mice gives rise to a transient immunosuppressive effect, as evaluated in vitro by lymphocyte transformation tests. This phenomenon occurs shortly after viral inoculation, at around 4-5 days, and regresses within thirty days.
Archives of Virology | 1987
A. Rhodes-Feuillette; F. Saal; J. Lasneret; Maud Santillana-Hayat; J. Peries
SummaryWe demonstrate that Simian Foamy viruses (SFV) types 1, 2, 4 and 10 do not induce Interferon (IFN) production in mouse and primate (simian and human) cell lines, but that their cytopathogenic effect is blocked by this viral inhibitor. The mechanisms of action of IFN seems to be different from that of other Retroviridae. No trapping of virions appears in treated cells examined by ectron microscopy. Moreover, neither precursor nor mature virus particles were observed in infected cultures submitted to IFN treatment.
Antimicrobial Agents and Chemotherapy | 2005
Jean Menotti; Maud Santillana-Hayat; Bruno Cassinat; Claudine Sarfati; Francis Derouin; Jean-Michel Molina
ABSTRACT Immune reconstitution might not be the only factor contributing to the low prevalence of microsporidiosis in human immunodeficiency virus (HIV)-infected patients treated with protease inhibitors, as these drugs may exert a direct inhibitory effect against fungi and protozoa. In this study, we developed a cell culture-quantitative PCR assay to quantify Encephalitozoon intestinalis growth in U-373-MG human glioblastoma cells and used this assay to evaluate the activities of six HIV aspartyl protease inhibitors against E. intestinalis. A real-time quantitative PCR assay targeted the E. intestinalis small-subunit rRNA gene. HIV aspartyl protease inhibitors were tested over serial concentrations ranging from 0.2 to 10 mg/liter, with albendazole used as a control. Ritonavir, lopinavir, and saquinavir were able to inhibit E. intestinalis growth, with 50% inhibitory concentrations of 1.5, 2.2, and 4.6 mg/liter, respectively, whereas amprenavir, indinavir, and nelfinavir had no inhibitory effect. Pepstatin A, a reference aspartyl protease inhibitor, could also inhibit E. intestinalis growth, suggesting that HIV protease inhibitors may act through the inhibition of an E. intestinalis-encoded aspartyl protease. These results showed that some HIV protease inhibitors can inhibit E. intestinalis growth at concentrations that are achievable in vivo and that the real-time quantitative PCR assay that we used is a valuable tool for the in vitro assessment of the activities of drugs against E. intestinalis.
Annales De L'institut Pasteur. Virologie | 1987
Maud Santillana-Hayat; Joëlle Tobaly-Tapiero; J. Lasneret; R. Emanoil-Ravier; J. Peries
Summary The transfection of canine and murine cells with DNA from simian foamy virus type 1 cell cultures led to the appearance of a cytopathic effect (CPE) similar to that induced by the original SFV1. High reverse transcriptase activity was present in supernatants of transfected cultures. Inoculation of these supernatants into permissive cells induced a syncytial CPE and high RNA-dependent DNA polymerase activity. These two effects were specifically inhibited by immune serum against SFV1. By electron microscopy, inoculated cultures showed the presence of virions homologous to those of SFV1.
Fems Immunology and Medical Microbiology | 2000
Sandra Fournier; Maud Santillana-Hayat; Emmanuelle Guillot; Claudine Sarfati; Nadine Dumoutier; Jean-Michel Molina; Francis Derouin
Fems Immunology and Medical Microbiology | 2006
Stephane Coupe; Karine Delabre; Régis Pouillot; Stephanie Houdart; Maud Santillana-Hayat; Francis Derouin
Nucleic Acids Research | 1988
Jean-Jacques Kupiec; Joëlle Tobaly-Tapiero; M. Canivet; Maud Santillana-Hayat; Rolf M. Flügel; Jorge Peries; Rodica Emanoil-Ravier
Journal of General Virology | 1991
Joëlle Tobaly-Tapiero; Jean-Jacques Kupiec; Maud Santillana-Hayat; Martine Canivet; J. Peries; Rodica Emanoil-Ravier